Search research articles
Contact Us
Filters
Showing results (121-130 of 306) with videos related to
Page
of 31
Sort By:
The Journal of Pharmacology and Experimental Therapeutics
|
November 11, 2018
Towards Further Verification of Physiologically-Based Kidney Models: Predictability of the Effects of Urine-Flow and Urine-pH on Renal Clearance
Takanobu Matsuzaki, Daniel Scotcher, Adam S Darwich, et al.
Biopharmaceutics & Drug Disposition
|
February 17, 2017
Optimization of intestinal microsomal preparation in the rat: A systematic approach to assess the influence of various methodologies on metabolic activity and scaling factors
Oliver J D Hatley, Christopher R Jones, Aleksandra Galetin, et al.
British Journal of Clinical Pharmacology
|
June 26, 2012
A pregnancy physiologically based pharmacokinetic (p-PBPK) model for disposition of drugs metabolized by CYP1A2, CYP2D6 and CYP3A4
Lu Gaohua, Khaled Abduljalil, Masoud Jamei, et al.
Fertility and Sterility
|
May 12, 2004
Monitoring plasma concentrations to individualize treatment with clomiphene citrate
Amin Rostami-Hodjegan, Martin S Lennard, Geoffrey T Tucker, et al.
Expert Opinion on Drug Metabolism & Toxicology
|
May 5, 2025
Pharmacotherapy in kidney disease: what it takes to move from general guidance to specific recommendations to stratified subgroups of patients - the tale of autosomal dominant polycystic kidney disease (ADPKD)
Annika C Tillmann, Amin Rostami-Hodjegan, Jill Barber, et al.
British Journal of Clinical Pharmacology
|
March 5, 2025
Variability in intestinal drug metabolizing enzymes and transporters in Crohn's disease and potential impact on oral drug absorption
Sarah Alrubia, Brahim Achour, Zubida M Al-Majdoub, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
December 23, 2009
Physiologically based mechanistic modelling to predict complex drug-drug interactions involving simultaneous competitive and time-dependent enzyme inhibition by parent compound and its metabolite in both liver and gut - the effect of diltiazem on the time-course of exposure to triazolam
Karen Rowland Yeo, Masoud Jamei, Jiansong Yang, et al.
Expert Opinion on Drug Metabolism & Toxicology
|
February 10, 2009
The Simcyp population-based ADME simulator
Masoud Jamei, Steve Marciniak, Kairui Feng, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
July 26, 2014
Lost in centrifugation: accounting for transporter protein losses in quantitative targeted absolute proteomics
Matthew D Harwood, Matthew R Russell, Sibylle Neuhoff, et al.
Current Drug Metabolism
|
November 6, 2007
Prediction of intestinal first-pass drug metabolism
Jiansong Yang, Masoud Jamei, Karen Rowland Yeo, et al.
Page
of 31
Search research articles
Search
Showing results (121-130 of 306) with videos related to
Sort By:
Page
of 31
The Journal of Pharmacology and Experimental Therapeutics
|
November 11, 2018
Towards Further Verification of Physiologically-Based Kidney Models: Predictability of the Effects of Urine-Flow and Urine-pH on Renal Clearance
Takanobu Matsuzaki, Daniel Scotcher, Adam S Darwich, et al.
Biopharmaceutics & Drug Disposition
|
February 17, 2017
Optimization of intestinal microsomal preparation in the rat: A systematic approach to assess the influence of various methodologies on metabolic activity and scaling factors
Oliver J D Hatley, Christopher R Jones, Aleksandra Galetin, et al.
British Journal of Clinical Pharmacology
|
June 26, 2012
A pregnancy physiologically based pharmacokinetic (p-PBPK) model for disposition of drugs metabolized by CYP1A2, CYP2D6 and CYP3A4
Lu Gaohua, Khaled Abduljalil, Masoud Jamei, et al.
Fertility and Sterility
|
May 12, 2004
Monitoring plasma concentrations to individualize treatment with clomiphene citrate
Amin Rostami-Hodjegan, Martin S Lennard, Geoffrey T Tucker, et al.
Expert Opinion on Drug Metabolism & Toxicology
|
May 5, 2025
Pharmacotherapy in kidney disease: what it takes to move from general guidance to specific recommendations to stratified subgroups of patients - the tale of autosomal dominant polycystic kidney disease (ADPKD)
Annika C Tillmann, Amin Rostami-Hodjegan, Jill Barber, et al.
British Journal of Clinical Pharmacology
|
March 5, 2025
Variability in intestinal drug metabolizing enzymes and transporters in Crohn's disease and potential impact on oral drug absorption
Sarah Alrubia, Brahim Achour, Zubida M Al-Majdoub, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
December 23, 2009
Physiologically based mechanistic modelling to predict complex drug-drug interactions involving simultaneous competitive and time-dependent enzyme inhibition by parent compound and its metabolite in both liver and gut - the effect of diltiazem on the time-course of exposure to triazolam
Karen Rowland Yeo, Masoud Jamei, Jiansong Yang, et al.
Expert Opinion on Drug Metabolism & Toxicology
|
February 10, 2009
The Simcyp population-based ADME simulator
Masoud Jamei, Steve Marciniak, Kairui Feng, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
July 26, 2014
Lost in centrifugation: accounting for transporter protein losses in quantitative targeted absolute proteomics
Matthew D Harwood, Matthew R Russell, Sibylle Neuhoff, et al.
Current Drug Metabolism
|
November 6, 2007
Prediction of intestinal first-pass drug metabolism
Jiansong Yang, Masoud Jamei, Karen Rowland Yeo, et al.
Page
of 31